Table 3 Patients included in the trial (N = 2094)a
Number (%) /mean (SD) | Randomised group | ||
|---|---|---|---|
| Â | Tele-medicine N = 1051 | Standard N = 1043 | Total N = 2094 |
LONDON (N = 1232) | Â | Â | Â |
Specialty | Â | Â | Â |
   Orthopaedics | 185 (30%) | 190(31%) | 375 (30%) |
   Urology | 117(19%) | 113(18%) | 230 (19%) |
   ENT | 109(18%) | 111 (18%) | 220(18%) |
   Gastroenterology | 117(19%) | 121 (20%) | 238 (19%) |
   Endocrinology | 42 (7%) | 28 (4%) | 70 (6%) |
   Rheumatology | 46 (7%) | 53 (9%) | 99 (8%) |
Sex | Â | Â | Â |
   Male | 301 (49%) | 291 (47%) | 592 (48%) |
   Female | 315(51%) | 325 (53%) | 640 (52%) |
Age (at randomisation in years) | Â | Â | Â |
   Mean (SD) | 49 (20) | 48 (20) | 48 (20) |
Age grouping | Â | Â | Â |
   Adults | 578 (94%) | 577 (94%) | 1155(94%) |
   Children (<16 years) | 38 (6%) | 39 (6%) | 77 (6%) |
WALES (N = 862) | Â | Â | Â |
Specialty | Â | Â | Â |
   Neurology | 43 (10%) | 38 (9%) | 81 (9%) |
   Urology | 29 (7%) | 35 (8%) | 64 (8%) |
   ENT | 186(43%) | 179 (42%) | 365 (42%) |
   Gastroenterology General Medicine | 98 (22%) 79 (18%) | 95 (22%) 80 (19%) | 193 (23%) 159(18%) |
Sex | Â | Â | Â |
   Male | 208 (48%) | 217(51%) | 425 (49%) |
   Female | 227 (52%) | 210(49%) | 437(51%) |
Age (at randomisation in years) | Â | Â | Â |
   Mean (SD) | 47(21) | 48 (22) | 48(21) |
Age grouping | Â | Â | Â |
   Adults | 384 (88%) | 385 (90%) | 769 (89%) |
   Children (<16 years) | 51 (12%) | 42 (10%) | 93(11%) |